Titan Pharmaceuticals
TTNP
#10416
Rank
$6.13 M
Marketcap
$4.61
Share price
-3.76%
Change (1 day)
18.81%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -$4.39

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$4.39. In 2023 the company made an earnings per share (EPS) of -$7.41 an increase over its 2022 EPS that were of -$15.19.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$4.39
2023-$7.41-51.22%
2022-$15.19-15.61%
2021-$18.00-81.37%
2020-$96.60-77.52%
2019-$429.80-56.32%
2018-$984.01-59.51%
2017-$2,431-371.81%
2016$894.19-144.35%
2015-$2,016300%
2014-$504.00-121.54%
2013$2,340-151.38%
2012-$4,554-11.54%
2011-$5,148188.89%
2010-$1,782-10%
2009-$1,980
2007-$8,118-2.38%
2006-$8,316-39.13%
2005-$13,662-16.87%
2004-$16,434-22.43%
2003-$21,1864.9%
2002-$20,19661.9%
2001-$12,474-13.7%
2000-$14,45465.01%
1999-$8,760-35.87%
1998-$13,660-1824.71%
1997$792.01-102.4%
1996-$33,066

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-$1.42-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-$0.24-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$3.38-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.36-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
$0.03000-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA